PremiumCompany AnnouncementsPersonalis Holds Virtual Annual Stockholders Meeting Personalis management to meet virtually with BTIG Guggenheim starts Personalis with a Buy, cites ‘best-in-class infrastructure’ PremiumThe FlyPersonalis price target raised to $9 from $8 at H.C. Wainwright Personalis Reports Strong Q1 Growth in Genomics Personalis reports Q1 EPS (18c), consensus (25c) PremiumThe FlyPersonalis updates on NeXT colorectal cancer detection study Personalis: Strategic Advancements and Market Potential Justify Buy Rating Craig-Hallum bullish on Personalis, initiates with a Buy